Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.52 -0.32 (-1.07%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Receivables - Net (2013 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) posted Receivables - Net of $25.45 million for the quarter ended Mar 31, 2026, down 52.7% from $53.8 million a year earlier but up 5.6% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Receivables - Net (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics' Receivables - Net came in at $23.39 million, down 54.5% from the prior year.

  • Annual Receivables - Net shows a five-year compound annual growth rate of -83.1% (years ended Dec 2020 to Dec 2025).
  • In prior years, Lakefront Biotherapeutics' Receivables - Net was $51.39 million in the year ended Dec 31, 2024 (+67.9%), $30.61 million in the year ended Dec 31, 2023 (-99.9%), $42.61 billion in the year ended Dec 31, 2022 (-67.7%) and $131.76 billion in the year ended Dec 31, 2021 (-22.2%).
  • Quarterly Receivables - Net has run from a low of $24.1 million in the quarter ended Dec 31, 2025 to a high of $127.37 billion in the quarter ended Dec 31, 2021 over five years.
  • On a year-over-year basis, Receivables - Net increased in two of the last six quarters, with an average decline of 7.5%.
  • The strongest year-over-year quarter for Receivables - Net in the past five years was the quarter ended Jun 30, 2021, with growth of 207.4%; the weakest was the quarter ended Dec 31, 2023, with a decline of 99.9%.
  • According to Business Quant data, Receivables - Net for the three prior quarters was $24.1 million (quarter ended Dec 31, 2025), $52.99 million (quarter ended Sep 30, 2025) and $62.82 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Lakefront Biotherapeutics 1.97 Bn 1.97 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 25.45 Mn
Dec 31, 2025 24.10 Mn
Sep 30, 2025 52.99 Mn
Jun 30, 2025 62.82 Mn
Mar 31, 2025 53.80 Mn
Dec 31, 2024 50.73 Mn
Sep 30, 2024 49.89 Mn
Mar 31, 2024 59.33 Mn
Dec 31, 2023 30.61 Mn
Sep 30, 2023 51.07 Mn
Mar 31, 2023 44.48 Mn
Dec 31, 2022 41.25 Bn
Mar 31, 2022 69.24 Mn
Dec 31, 2021 127.37 Bn
Jun 30, 2021 106.14 Mn
Dec 31, 2020 176.96 Bn
Jun 30, 2020 34.53 Mn
Mar 31, 2020 29.91 Mn
Dec 31, 2019 59.78 Mn
Sep 30, 2019 36.32 Mn
API Access

Lakefront Biotherapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=LKFT&period=max&api_key=YOUR_API_KEY